Publication | Closed Access

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial

Hereditary Angio-oedemaCardiovascular DiseaseMedicineVascular BiologyPharmacotherapyPlacebo-controlled Crossover TrialAngiologyPhase 2PharmacologyAtherosclerosis